Cargando…

Gabapentin Administration Reduces Reactive Gliosis and Neurodegeneration after Pilocarpine-Induced Status Epilepticus

The lithium-pilocarpine model of epilepsy reproduces in rodents several features of human temporal lobe epilepsy, by inducing an acute status epilepticus (SE) followed by a latency period. It has been proposed that the neuronal network reorganization that occurs during latency determines the subsequ...

Descripción completa

Detalles Bibliográficos
Autores principales: Rossi, Alicia Raquel, Angelo, Maria Florencia, Villarreal, Alejandro, Lukin, Jerónimo, Ramos, Alberto Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826740/
https://www.ncbi.nlm.nih.gov/pubmed/24250797
http://dx.doi.org/10.1371/journal.pone.0078516
_version_ 1782290952366325760
author Rossi, Alicia Raquel
Angelo, Maria Florencia
Villarreal, Alejandro
Lukin, Jerónimo
Ramos, Alberto Javier
author_facet Rossi, Alicia Raquel
Angelo, Maria Florencia
Villarreal, Alejandro
Lukin, Jerónimo
Ramos, Alberto Javier
author_sort Rossi, Alicia Raquel
collection PubMed
description The lithium-pilocarpine model of epilepsy reproduces in rodents several features of human temporal lobe epilepsy, by inducing an acute status epilepticus (SE) followed by a latency period. It has been proposed that the neuronal network reorganization that occurs during latency determines the subsequent appearance of spontaneous recurrent seizures. The aim of this study was to evaluate neuronal and glial responses during the latency period that follows SE. Given the potential role of astrocytes in the post-SE network reorganization, through the secretion of synaptogenic molecules such as thrombospondins, we also studied the effect of treatment with the α2δ1 thrombospondin receptor antagonist gabapentin. Adult male Wistar rats received 3 mEq/kg LiCl, and 20 h later 30 mg/kg pilocarpine. Once SE was achieved, seizures were stopped with 20 mg/kg diazepam. Animals then received 400 mg/kg/day gabapentin or saline for either 4 or 14 days. In vitro experiments were performed in dissociated mixed hippocampal cell culture exposed to glutamate, and subsequently treated with gabapentin or vehicle. During the latency period, the hippocampus and pyriform cortex of SE-animals presented a profuse reactive astrogliosis, with increased GFAP and nestin expression. Gliosis intensity was dependent on the Racine stage attained by the animals and peaked 15 days after SE. Microglia was also reactive after SE, and followed the same pattern. Neuronal degeneration was present in SE-animals, and also depended on the Racine stage and the SE duration. Polysialic-acid NCAM (PSA-NCAM) expression was increased in hippocampal CA-1 and dentate gyrus of SE-animals. Gabapentin treatment was able to reduce reactive gliosis, decrease neuronal loss and normalize PSA-NCAM staining in hippocampal CA-1. In vitro, gabapentin treatment partially prevented the dendritic loss and reactive gliosis caused by glutamate excitotoxicity. Our results show that gabapentin treatment during the latency period after SE protects neurons and normalizes PSA-NCAM probably by direct interaction with neurons and glia.
format Online
Article
Text
id pubmed-3826740
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-38267402013-11-18 Gabapentin Administration Reduces Reactive Gliosis and Neurodegeneration after Pilocarpine-Induced Status Epilepticus Rossi, Alicia Raquel Angelo, Maria Florencia Villarreal, Alejandro Lukin, Jerónimo Ramos, Alberto Javier PLoS One Research Article The lithium-pilocarpine model of epilepsy reproduces in rodents several features of human temporal lobe epilepsy, by inducing an acute status epilepticus (SE) followed by a latency period. It has been proposed that the neuronal network reorganization that occurs during latency determines the subsequent appearance of spontaneous recurrent seizures. The aim of this study was to evaluate neuronal and glial responses during the latency period that follows SE. Given the potential role of astrocytes in the post-SE network reorganization, through the secretion of synaptogenic molecules such as thrombospondins, we also studied the effect of treatment with the α2δ1 thrombospondin receptor antagonist gabapentin. Adult male Wistar rats received 3 mEq/kg LiCl, and 20 h later 30 mg/kg pilocarpine. Once SE was achieved, seizures were stopped with 20 mg/kg diazepam. Animals then received 400 mg/kg/day gabapentin or saline for either 4 or 14 days. In vitro experiments were performed in dissociated mixed hippocampal cell culture exposed to glutamate, and subsequently treated with gabapentin or vehicle. During the latency period, the hippocampus and pyriform cortex of SE-animals presented a profuse reactive astrogliosis, with increased GFAP and nestin expression. Gliosis intensity was dependent on the Racine stage attained by the animals and peaked 15 days after SE. Microglia was also reactive after SE, and followed the same pattern. Neuronal degeneration was present in SE-animals, and also depended on the Racine stage and the SE duration. Polysialic-acid NCAM (PSA-NCAM) expression was increased in hippocampal CA-1 and dentate gyrus of SE-animals. Gabapentin treatment was able to reduce reactive gliosis, decrease neuronal loss and normalize PSA-NCAM staining in hippocampal CA-1. In vitro, gabapentin treatment partially prevented the dendritic loss and reactive gliosis caused by glutamate excitotoxicity. Our results show that gabapentin treatment during the latency period after SE protects neurons and normalizes PSA-NCAM probably by direct interaction with neurons and glia. Public Library of Science 2013-11-08 /pmc/articles/PMC3826740/ /pubmed/24250797 http://dx.doi.org/10.1371/journal.pone.0078516 Text en © 2013 Rossi et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Rossi, Alicia Raquel
Angelo, Maria Florencia
Villarreal, Alejandro
Lukin, Jerónimo
Ramos, Alberto Javier
Gabapentin Administration Reduces Reactive Gliosis and Neurodegeneration after Pilocarpine-Induced Status Epilepticus
title Gabapentin Administration Reduces Reactive Gliosis and Neurodegeneration after Pilocarpine-Induced Status Epilepticus
title_full Gabapentin Administration Reduces Reactive Gliosis and Neurodegeneration after Pilocarpine-Induced Status Epilepticus
title_fullStr Gabapentin Administration Reduces Reactive Gliosis and Neurodegeneration after Pilocarpine-Induced Status Epilepticus
title_full_unstemmed Gabapentin Administration Reduces Reactive Gliosis and Neurodegeneration after Pilocarpine-Induced Status Epilepticus
title_short Gabapentin Administration Reduces Reactive Gliosis and Neurodegeneration after Pilocarpine-Induced Status Epilepticus
title_sort gabapentin administration reduces reactive gliosis and neurodegeneration after pilocarpine-induced status epilepticus
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826740/
https://www.ncbi.nlm.nih.gov/pubmed/24250797
http://dx.doi.org/10.1371/journal.pone.0078516
work_keys_str_mv AT rossialiciaraquel gabapentinadministrationreducesreactivegliosisandneurodegenerationafterpilocarpineinducedstatusepilepticus
AT angelomariaflorencia gabapentinadministrationreducesreactivegliosisandneurodegenerationafterpilocarpineinducedstatusepilepticus
AT villarrealalejandro gabapentinadministrationreducesreactivegliosisandneurodegenerationafterpilocarpineinducedstatusepilepticus
AT lukinjeronimo gabapentinadministrationreducesreactivegliosisandneurodegenerationafterpilocarpineinducedstatusepilepticus
AT ramosalbertojavier gabapentinadministrationreducesreactivegliosisandneurodegenerationafterpilocarpineinducedstatusepilepticus